InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by HILL MATTHEW C, Chief Financial Officer. Insider active across 1 companies, notably PDS Biotechnology Corp. Cumulatively, 2 filings have been recorded. Total volume traded: €40k. The latest transaction was disclosed on 13 December 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€19,8912,500 shares@ €7.9563100.0% of flow
Common Stock
SEC:0001140361-21-041473·
Ideal exit: 9 Sept 2022 (T+270)
€19,8912,500 shares@ €7.95630.047% mcap50.0% of flow
Common Stock
SEC:0001140361-21-041473:0·
Ideal exit: 9 Sept 2022 (T+270)
2 of 2 declarations
About HILL MATTHEW C
Matthew C. Hill is the Chief Financial Officer at PDS Biotechnology Corp. He oversees financial management and budgeting strategies for the company. His expertise is essential for ensuring the financial health and compliance of the firm.
